Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Common Equity (2020 - 2025)

Definitive Healthcare (DH) has disclosed Common Equity for 6 consecutive years, with $379.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity fell 37.58% year-over-year to $379.0 million, compared with a TTM value of $379.0 million through Dec 2025, down 37.58%, and an annual FY2025 reading of $379.0 million, down 37.58% over the prior year.
  • Common Equity was $379.0 million for Q4 2025 at Definitive Healthcare, down from $389.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $1.5 billion in Q4 2021 and bottomed at $379.0 million in Q4 2025.
  • Average Common Equity over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Common Equity increased 26.34% in 2022, then plummeted 63.52% in 2025.
  • Year by year, Common Equity stood at $1.5 billion in 2021, then fell by 1.19% to $1.5 billion in 2022, then decreased by 19.08% to $1.2 billion in 2023, then tumbled by 49.37% to $607.2 million in 2024, then plummeted by 37.58% to $379.0 million in 2025.
  • Business Quant data shows Common Equity for DH at $379.0 million in Q4 2025, $389.7 million in Q3 2025, and $411.2 million in Q2 2025.